Biotech

All Articles

F 2G increases $100M for 2nd try to get new antifungal to market

.After F2G's initial effort to acquire a brand-new lesson of antifungal to market was hindered by th...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 systems in the middle of earnings tensions

.Moderna has actually sworn to reduce R&ampD costs through $1.1 billion by 2027. The selection to re...

Sanofi's $80M bet on Fulcrum dystrophy medicine ends in stage 3 fail

.Simply four months after Sanofi wager $80 thousand in upfront money on Fulcrum Therapeutics' losmap...

Oncternal stock drains 60% amid discharges, trial firings

.Cancer cells firm Oncternal Therapeutics is actually folding all its clinical trials and also givin...

Roche is holding out hopes that its own injectable being overweight prospect might ultimately display 25% weight loss in late-stage trial

.Roche is holding out chances that its own injectable being overweight possibility could eventually ...

Novo Nordisk barrages 'exceptional' weight-loss result for dual-acting dental medication in early trial

.Novo Nordisk has actually lifted the lid on a period 1 trial of its own oral amylin and also GLP-1 ...

AbbVie sues BeiGene over blood cancer drug proprietary knowledge

.Only a handful of short weeks after gaining an FDA Fast lane tag for its own investigational BTK de...

Lilly supplies one-two blow along with second tranche of favorable records on once a week the hormone insulin applicant

.Not long after a positive data decrease for Eli Lilly's efsitora alfa, the Indianapolis-based compa...

BridgeBio cuts genetics treatment budget plan as scientific records let down

.BridgeBio Pharma is actually slashing its own gene therapy spending plan and also drawing back comi...

GSK submits HSV injection really hopes after phase 2 fall short, transferring race to Moderna, BioNTech

.GSK's attempt to build the very first vaccine for genital herpes simplex infection (HSV) has finish...